For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Nicotine gum is a smoking cessation product that helps smokers to slowly overcome nicotine addiction. Nicotine is released by chewing the gum and is absorbed into the blood stream through the lining of the mouth, which helps smokers to slowly reduce their craving for nicotine. It is one of nicotine replacement therapies (NRT's) and it is an over-the-counter medication.
The nicotine gum is available in various dosages and can be consumed according to the level of addiction.
Scope of the Report:
Nicotine gum downstream is smokers. In recent years, the main consumption areas are US and Europe. There are about 1.3 billion smokers in global. Increasing more and more people quit smoking is expected to drive the demand for the nicotine gum market.
The industry is affected by the economy and policy, so it's important to put an eye to economy indexes and lesder's prefer. With the global economic recovery, more and more people pay attention to health, especially in developed regions.
Nicotine gum sales increase in developed markets, like those in Western Europe, where quit smoking rates is increasing and where tobacco company operations are more restricted by government policies, compared to emerging markets.
The worldwide market for Nicotine Gum is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Nicotine Gum in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Pharmacia(Pfizer)
- Novartis
- Perrigo Company
- Fertin Pharma
- Revolymer
- Johnson & Johnson
- Cambrex Corporation
- GlaxoSmithKline(GSK )
- Reynolds American
- Alchem International
- Dr. Reddy's Laboratories
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- 2 mg/piece of gum dosage
- 4 mg/piece of gum dosage
Market Segment by Applications, can be divided into
- Withdrawal Clinics
- Medical Practice
- Individual Smokers
- Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nicotine Gum product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nicotine Gum, with price, sales, revenue and global market share of Nicotine Gum in 2017 and 2018.
Chapter 3, the Nicotine Gum competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicotine Gum breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Nicotine Gum market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Nicotine Gum sales channel, distributors, customers, research findings and conclusion, appendix and data source.